A Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between a Fixed Dose Combination of Fimasartan/Amlodipine and Co-administration of Fimasartan and Amlodipine in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Amlodipine/fimasartan (Primary)
- Indications Essential hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 08 Feb 2017 Status changed from recruiting to completed.
- 25 Nov 2016 Status changed from not yet recruiting to recruiting.
- 03 Oct 2016 New trial record